These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3554822)

  • 1. Evaluation of the structure function relationships of MHC class I antigens by molecular genetic techniques.
    Koeller D; Ozato K
    Year Immunol; 1986; 2():195-204. PubMed ID: 3554822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
    Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
    Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between CD4 and MHC class II molecules and its effect on T cell function.
    Vignali DA
    Behring Inst Mitt; 1994 Jul; (94):133-47. PubMed ID: 7998907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of major histocompatibility complex.
    Gill TJ
    Arch Pathol Lab Med; 1980 Nov; 104(11):559-62. PubMed ID: 6932830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of H-2 T (Tla) region class I MHC molecules.
    Teitell M; Cheroutre H; Panwala C; Holcombe H; Eghtesady P; Kronenberg M
    Crit Rev Immunol; 1994; 14(1):1-27. PubMed ID: 7741975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro mutagenesis of a mouse MHC class I gene for the examination of structure-function relationships.
    Shiroishi T; Evans GA; Appella E; Ozato K
    J Immunol; 1985 Jan; 134(1):623-9. PubMed ID: 3964822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC: function and implication on vaccine development.
    Eckels DD
    Vox Sang; 2000; 78 Suppl 2():265-7. PubMed ID: 10938966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface markers, antigens, and receptors on murine T and B cells: part 2.
    Ahmed A; Smith AH
    Crit Rev Immunol; 1983; 4(1):19-94. PubMed ID: 6131792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
    Algarra I; García-Lora A; Cabrera T; Ruiz-Cabello F; Garrido F
    Cancer Immunol Immunother; 2004 Oct; 53(10):904-10. PubMed ID: 15069585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMGT unique numbering for MHC groove G-DOMAIN and MHC superfamily (MhcSF) G-LIKE-DOMAIN.
    Lefranc MP; Duprat E; Kaas Q; Tranne M; Thiriot A; Lefranc G
    Dev Comp Immunol; 2005; 29(11):917-38. PubMed ID: 15936075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.